The majority of CMOs’ reading this will know it is not so simple for them to navigate this highly emotive topic in a time of hybrid working. With increasingly distributed teams, the challenge of keeping everyone up-to-date and focused is an ever-present concern for every CMO.

It was the best of times, it was the worst of times. Destiny 2 has just launched its newest Lightfall expansion this week, which on launch day, managed to break the game’s all-time concurrent Steam record, despite the fact we’re five years into this live service sequel. It’s impressive, and speaks highly of how much hype there was for Lightfall heading into release.

Supply chain pressures have eased and will continue to do so. This will help companies produce goods and services to meet buyer demand. Price statistics will also look better. Although overall inflation reflects excessive stimulus to the economy, the month-to-month numbers will be better as factories are less limited by supply problems.

Back in 1994, the bow-tie wearing star of Bill Nye the Science Guy appeared before the Federal Communications Commission to argue against a proposed rule that would keep his show from counting towards the three hours of educational programming a week required by the Children’s Television Act. The FCC only wanted to count shows whose “primary purpose” was educational, but Nye testified he was “100% certain” his show was more than half entertainment. “If a program isn’t entertaining and enjoyable for children, they won’t watch,” he lectured the commissioners, who relented, deciding a show only had to have education as a “significant” purpose to count. “They wanted it to be didactic, they wanted it to follow a syllabus of some sort,” recalls the triumphant Nye.

We believe that Procter & Gamble stock (NYSE: PG) and Colgate-Palmolive stock (NYSE: CL) in the consumer-defensive sector, can be avoided. Still, if one has to invest in one of these two companies, P&G is likely a better pick, in our view. Although P&G is trading at a comparatively higher valuation of 4.0x trailing revenues vs. 3.4x for Colgate-Palmolive, this gap in the valuation makes sense, given the former’s superior revenue growth, profitability, and financial position, as discussed below.

Scientists have made enormous discoveries that have helped elucidate how to diagnose, treat, and vaccinate against Covid-19. Despite these breakthroughs, there is much more researchers and scientists are learning and still need to learn in order to tackle the challenges brought upon by the pandemic. Below are three questions they should investigate-